HCG Cancer Hospital, Borivali, Mumbai, successfully hosted ROBOCAN 1.0, a Continuing Medical Education (CME) session themed “Robotic Surgery: Redefining Cancer Care with Robotic Excellence,” bringing together oncologists, surgeons, and healthcare professionals to explore the expanding role of robotic-assisted surgery in cancer treatment.

The initiative focused on strengthening clinical understanding and accelerating the adoption of minimally invasive, precision-driven surgical approaches. With limited access to advanced oncology technologies in parts of Mumbai’s western suburbs, the session served as a key platform to bridge knowledge gaps and introduce next-generation surgical techniques.

Scientific discussions covered a wide spectrum of specialties, including urology, head and neck cancers, gastrointestinal cancers, and gynecological oncology. Experts highlighted how robotic-assisted procedures are improving surgical precision, reducing complications, and enabling faster recovery.

Saket Sathe, Consultant – Uro Oncology & Robotic Surgery, said, “Robotic surgery has transformed the management of urological cancers by offering superior precision, reduced complications, and quicker recovery, ultimately improving patient outcomes.”

Chandrakant Pancholi, Consultant – Uro Oncology & Robotic Surgery, added, “The transition to robotic-assisted procedures is not just technological but transformational, enabling safer and more effective surgical interventions.”

Tirathram Kaushik, Consultant – GI, HPB, Gynecological & Thoracic Oncology & Robotic Surgery, noted that robotic surgery is increasingly enabling safer and more precise interventions even in complex and anatomically challenging cases.

The CME also spotlighted advancements in head and neck oncology, including the Bilateral Axillo-Breast Approach (BABA), which enables scarless surgeries with improved cosmetic and functional outcomes. Yash Mathur, Senior Consultant – Head & Neck Oncology & Robotic Surgery, emphasized that such innovations help reduce post-surgical disfigurement while preserving patient confidence.

Avik Chauhan, Cluster Chief Operating Officer, Mumbai, said, “Robotic surgery is a significant step forward in making cancer treatment more precise and patient-friendly. At HCG, we are committed to bringing such advanced technologies closer to patients and ensuring better clinical outcomes through continuous innovation.”